Taurine for cataract

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Jul 2023: Trial started, NCT06639711
  2. 15 Oct 2024: Trial registered, NCT06639711

The trials

NCT06639711: Taurine Eye Drops May Prevent the Progression of Cataract

State
Under way
Phase
Phase 1 and Phase 2
People
50 taking part
Started
10 Jul 2023
Primary completion
20 Dec 2024
Arms
Application of Taurine-containing Eye Drops
Results
None posted
  1. 10 Jul 2023: Trial started
  2. 15 Oct 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.